A detailed history of Hardin Capital Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Hardin Capital Partners, LLC holds 5,022 shares of JNJ stock, worth $815,070. This represents 0.44% of its overall portfolio holdings.

Number of Shares
5,022
Previous 5,340 5.96%
Holding current value
$815,070
Previous $853 Million 14.83%
% of portfolio
0.44%
Previous 0.48%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$143.34 - $165.86 $45,582 - $52,743
-318 Reduced 5.96%
5,022 $726 Million
Q3 2024

Oct 18, 2024

BUY
$145.48 - $167.38 $2,036 - $2,343
14 Added 0.26%
5,340 $853 Million
Q2 2024

Aug 08, 2024

BUY
$144.38 - $157.78 $768,967 - $840,336
5,326 New
5,326 $778 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hardin Capital Partners, LLC Portfolio

Follow Hardin Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardin Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardin Capital Partners, LLC with notifications on news.